Published online April 14, 2008
PEDIATRICS Vol. 121 No. 5 May 2008, pp. e1223-e1228 (doi:10.1542/peds.2007-2062)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacpoole, P. W.
Right arrow Articles by Shuster, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stacpoole, P. W.
Right arrow Articles by Shuster, J. J.
Related Collections
Right arrow Nutrition & Metabolism
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Evaluation of Long-term Treatment of Children With Congenital Lactic Acidosis With Dichloroacetate

Peter W. Stacpoole, PhD, MDa,b,c, Lesa R. Gilbert, RNa, Richard E. Neiberger, MD, PhDd, Paul R. Carney, MDd,e,f, Edward Valenstein, MDe, Douglas W. Theriaque, MSc and Jonathan J. Shuster, PhDc,g

a Departments of Medicine
b Biochemistry and Molecular Biology
d Pediatrics
e Neurology
f Biomedical Engineering
g Epidemiology and Health Policy Research
c General Clinical Research Center, University of Florida, Gainesville, Florida

OBJECTIVE. The purpose of this research was to report results on long-term administration of dichloroacetate in 36 children with congenital lactic acidosis who participated previously in a controlled trial of this drug.

PATIENTS AND METHODS. We conducted a randomized control trial, followed by an open-label study. Data were analyzed for each patient from the time they began treatment through May 2005.

RESULTS.Subject exposure to dichloroacetate totaled 110.42 years. Median height and weight increased over time, but the standardized values declined slightly and remained below the first percentile. There were no significant changes in biochemical metabolic indices, except for a 2% rise in total protein and a 22% increase in 24-hour urinary oxalate. Both the basal and carbohydrate meal-induced rises in lactate were blunted by dichloroacetate. The median cerebrospinal fluid lactate also decreased over time. Conduction velocity decreased and distal latency increased in peroneal nerves. Mean 3-year survival for all of the subjects was 79%.

CONCLUSIONS. Oral dichloroacetate is generally well tolerated in young children with congenital lactic acidosis. Although continued dichloroacetate exposure is associated with evidence of peripheral neuropathy, it cannot be determined whether this is attributable mainly to the drug or to progression of underlying disease.

Key Words: dichloroacetate • lactic acidosis • mitochondria • pyruvate dehydrogenase • respiratory chain

Abbreviations: CLA—congenital lactic acidosis • GCRC—General Clinical Research Center

Accepted Oct 4, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Liu, J. Wu, J. Zhu, C. Kuei, J. Yu, J. Shelton, S. W. Sutton, X. Li, S. J. Yun, T. Mirzadegan, et al.
Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81
J. Biol. Chem., January 30, 2009; 284(5): 2811 - 2822.
[Abstract] [Full Text] [PDF]